Editor’s Note
APRIL 2010
OR leaders are striving to make evidence-based decisions about new technology. OR Manager, Inc, and ECRI Institute have joined in a collaboration to bring quarterly supplements with summaries of the Institute’s technology assessment reports to OR Manager readers. ECRI Institute is an independent nonprofit organization that researches best approaches to improving patient care. It does its work by analyzing the research literature and data on clinical procedures, medical devices, and drug therapies.
This summary of ECRI Institute’s Emerging Technology Evidence Report provides a review of the literature through August 2009.
Total ankle replacement (TAR) involves replacing an injured or diseased ankle joint with an artificial joint. TAR is intended as an alternative to ankle fusion in patients with debilitating end-stage arthritis, loss of ankle function, and pain that is refractory to conservative treatment. Ankle fusion is considered the standard of care, but a fused joint may prevent flexion and extension of the foot and limit side-to-side motion. The purported benefit of TAR over ankle fusion is preserved range of motion (ROM).
Early-generation fixed-bearing implants consisted of two metal components cemented into the tibia and talus. New mobile-bearing implants have a third component (polyethylene bearing) that glides between the two metal components, are porous coated, and do not require cement.
Surgeons perform TAR through a single anterior incision or through both anterior and lateral incisions. The procedure takes 2 to 3 hours. Patients are hospitalized for up to 4 days.
SUPPLEMENT TO OR MANAGER Vol 26, No 4, April 2010